Vanguard Group »

Nurix Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $38M 2.6M 14.70
2023-12-31 $27M 2.6M 10.32
2023-09-30 $21M 2.7M 7.86
2023-06-30 $27M 2.7M 9.99
2023-03-31 $23M 2.6M 8.88
2022-12-31 $24M 2.2M 10.98
2022-06-30 $27M 2.1M 12.67
2022-03-31 $28M 2.0M 14.01
2021-09-30 $59M 2.0M 29.96
2021-06-30 $39M 1.5M 26.53
2021-03-31 $36M 1.2M 31.09
2020-12-31 $20M 618k 32.88
2020-09-30 $19M 536k 34.91